Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01496846 · ClinicalTrials.gov registry record · Phase 4
Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars
A Phase 4 study of Irreversible Pulpitis, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 4
- Development phase
- 201
- Enrollment target
- 1
- Study location
NCT01496846 is a Phase 4 study of Irreversible Pulpitis that has completed, run by University of Michigan. The registered enrollment target is 201 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01496846, a Phase 4 study of Irreversible Pulpitis, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 201 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to study the ability of a frequently used dental anesthetic (articaine) to achieve complete numbness of a diseased tooth with the most commonly used injection technique in the lower jaw (inferior alveolar nerve block: IANB). If this technique fails, a commonly used supplemental (SUP) technique with one of two possible dental anesthetics (lidocaine or articaine) will be given to evaluate the success/failure of complete numbness between the two anesthetics. Standardized administration of anesthesia is provided by controlled delivery using Midwest Comfort Control Syringe. The investigators hypothesize that supplemental infiltration anesthesia with articaine will give the same success rate as lidocaine in achieving complete pulpal anesthesia in mandibular molars with irreversible pulpits. This study consisted of two periods of patient enrollment, treatment and data collection: Part I: 101 subjects; Part II: 100 subjects.
Conditions Studied
Interventions
- DRUG IANB Articaine
- DRUG SUP Articaine
- DRUG SUP Lidocaine
Study Locations (1)
Michigan
- University of Michigan, School of Dentistry Clinics - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2011-09 |
| Est. Completion | 2016-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01496846
The ClinicalTrials.gov registry entry for NCT01496846 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Irreversible Pulpitis appearing as the primary indexed condition, and to 3 interventions - of which IANB Articaine is the first listed.
NCT01496846 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01496846 about?
NCT01496846 is a clinical study titled "Efficacy Study of Articaine Versus Lidocaine as Supplemental Infiltration in Inflamed Molars". The purpose of this trial is to study the ability of a frequently used dental anesthetic (articaine) to achieve complete numbness of a diseased tooth with the most commonly used injection technique in the lower jaw (inferior alveolar nerve block: IANB). If this technique fails, a commonly used suppl...
What is the current status of trial NCT01496846?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 201 participants. The study started on 2011-09. Estimated completion is 2016-02.
What conditions does trial NCT01496846 study?
This clinical trial studies the following conditions: Irreversible Pulpitis.
What interventions are being tested in trial NCT01496846?
The interventions under investigation include: IANB Articaine (DRUG), SUP Articaine (DRUG), SUP Lidocaine (DRUG).
Who is sponsoring clinical trial NCT01496846?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01496846 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irreversible Pulpitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.